Primary structure of human proacrosin deduced from its cDNA sequence  by Baba, Tadashi et al.
Volume 244, number 2, 296-300 FEB 06821 February 1989 
Primary structure of human proacrosin deduced from its cDNA 
sequence 
Tadashi Baba, Ken Watanabe, Shin-ichi Kashiwabara and Yuji Arai 
Institute of Applied Biochemistry, University of Tsukuba, Ibaraki 30.5, Japan 
Received 26 October 1988; revised version received 23 December 1988 
cDNA clones encoding proacrosin, the zymogen of acrosin, were isolated from a human testis cDNA library by using 
a fragment of boar acrosin cDNA as a probe. Nucleotide sequencing of the longest cDNA clone has predicted that human 
proacrosin is synthesized with a 19-amino-acid signal peptide at the N-terminus. The cleavable signal sequence is followed 
by a 23-residue segment corresponding to the light chain and then by a 379-residue stretch that constitutes the heavy 
chain containing the catalytic site of the mature protease. The C-terminal portion of the deduced sequence for the heavy 
chain is very rich in proline residues, most of which are encoded by a unique repeat of CCCCCA. The active-site residues 
including histidine, aspartic acid, and serine are also predicted to be located at residues 69, 123, and 221, respectively. 
Acrosin; Serine protease; Amino acid sequence; cDNA; (Human testis) 
1. INTRODUCTION 
Acrosin is an endoprotease occurring in the 
acrosomes that cover the anterior part of the sperm 
head [l]. On the basis of the substrate specificity 
[2,3], inhibition profile [3], and N-terminal amino 
acid sequence [4,5], acrosin is thought to belong to 
the family of serine proteases. Like other members 
of this family, acrosin is synthesized as an en- 
zymatically inactive precursor, proacrosin, and 
converted to the mature form by limited pro- 
teolysis [ 11. 
Most of the biochemical data on (pro)acrosin 
have been obtained by using boar sperms [6,7]. 
Boar acrosin and its precursor (zymogen) have 
been reported to possess apparent molecular 
masses of 34-40 and 53-55 kDa, respectively 
[5-91. The mature enzyme is a two-chain protein 
consisting of a 23-residue light chain and a heavy 
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chain containing the functionally active site, the 
two chains being covalently linked by two disulfide 
bridges [5]. On the other hand, our recent results 
indicate that the zymogen is a single-chain 
polypeptide containing a segment corresponding to 
the light chain at its N-terminus [lo]. It is, 
therefore, conceivable that boar proacrosin is con- 
verted to the mature enzyme by two activation pro- 
cesses, i.e. the liberation of proenzyme segments 
from the C-terminus and cleavage of a peptide 
bond producing the light and heavy chains. In con- 
trast to the case for the boar (pro)enzyme, 
biochemical information concerning human 
(pro)acrosin is still very limited. For instance, con- 
siderably variable values have been reported for 
the molecular masses of human proacrosin and 
acrosin [ll-181. 
To facilitate further studies of human 
(pro)acrosin, it is necessary to establish the struc- 
tures of its protein and gene. Here, we report the 
isolation of proacrosin cDNA clones from a 
human testis cDNA library. The primary structure 
of human (pro)acrosin deduced from the 
nucleotide sequence of the cloned cDNA is also 
reported. 
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2. EXPERIMENTAL 
A cDNA library in hgtll consisting of 1.4 x lo6 independent 
clones (average insert size, 1.2 kbp) was prepared from boar 
testis poly(A)+ RNA [19]. Approx. 7 x 10’ phages were 
screened with polyclonal rabbit anti-boar acrosin antibodies 
that had been purified by chromatography on an acrosin- 
conjugated Sepharose 4B column. Horseradish peroxidase- 
conjugated goat anti-rabbit IgG antibodies (Jackson Im- 
munoresearch Labs) were used to detect antibody-binding 
clones. Positive clones were selected and plaque-purified. The 
DNA was isolated and digested with EcoRI, and the cDNA in- 
serts were subcloned into pUC19 for restriction mapping and 
nucleotide sequencing. Another hgtl 1 library from human testis 
(Clontech) were screened by the plaque hybridization method 
[20] using a cDNA fragment for boar acrosin as a probe. The 
probe was labelled by the random-primer technique using a 
DNA labelling kit (Nippon Gene) and [a-32P]dCTP 
(6000 Ci/mmol, Amersham) according to the supplier’s pro- 
tocol. Positive clones were plaque-purified, and the insert DNA 
was isolated and digested with restriction enzymes. The DNA 
fragments were subcloned into M13mp18 or 19, or pUC19 at 
appropriate restriction sites. The nucleotide sequences of the 
subcloned inserts were determined by the dideoxy chain- 
termination method [21] using an Ml3 sequencing kit 
(Toyobo), a ‘I-deaza sequencing kit (Takara), or a SequenaseTM 
(US Biochemical Corp.). 
3. RESULTS 
Screening of the boar testis cDNA library with 
affinity-purified antibodies to boar acrosin yielded 
four immunopositive clones, XPAl, XPA2, XPA3, 
and hPA4, having cDNA inserts of 1.7, 1.4, 0.6, 
and 0.7 kbp, respectively. The APA insert had an 
internal EcoRI site and formed two fragments 695 
(PA3) and 646 bp long (PA4). Sequence analysis 
of PA4 indicated that it contained an open reading 
frame encoding 215 amino acid residues including 
the N-terminal 75 residues previously determined 
for purified boar (pro)acrosin [4,5,10]. We thus 
concluded that PA4 was an authentic fragment of 
boar acrosin cDNA (details will be reported 
elsewhere). 
When 8 x 104 hgtll recombinant phages from a 
human testis cDNA library were screened using 
PA4 as a probe, three positive clones, termed H4, 
H8, and H9, were obtained. Since the inserts of 
these clones had similar restriction maps, the 
nucleotide sequence of the insert of the longest 
clone, H4, was determined according to the 
strategy shown in fig. 1. Partial DNA sequences of 
the H8 and H9 inserts showed that they were 
related to the H4 insert (not shown). The H4 
cDNA was 1388 bp in length and contained an 
open reading frame of 1263 nucleotides (421 amino 
acids) starting from an ATG initiation codon at 
nucleotides 17-19 (fig.2). The open reading frame 
was followed by a 3 ’ -noncoding region 94 
nucleotides long. Three overlapping polyadenyla- 
tion signals (AATAAATAAATAAA) were 
located 17 nucleotides upstream from the poly(A)+ 
addition site. 
The deduced amino acid sequence of human 
proacrosin along with the N-terminal 75-residue 
sequence covering the light chain and a part of the 
heavy chain of boar (pro)acrosin [4,5, lo] is shown 
in fig.2. In this 75-residue region, the sequence 
similarity between human and boar proacrosins 
was almost 75 olo . The high similarity indicated that 
the H4 insert was actually a cDNA encoding 
human proacrosin consisting of the light and heavy 
chains (residues l-23 and 24-402, respectively). 
The amino acid sequence at residues - 19 to - 1 
was strongly hydrophobic. It seemed to be a 
cleavable signal peptide required for translocation 
of the newly synthesized protein across a mem- 
brane. Thus, the cDNA-derived sequence indicated 
that human proacrosin contained 402 amino acids 
with a molecular mass of 43 860 Da. Two potential 
N-linked glycosylation sites were found at residues 
3 and 191. There was a proline-rich region at the 
C-terminal portion of the protein (residues 
283-353). Moreover, the prolines at residues 
325-353 were mostly encoded by a unique repeat 
of CCCCCA. The amino acid composition of 
human proacrosin predicted from the cDNA- 
derived sequence is shown in table 1 together with 
that of boar proacrosin determined by us [lo]. 
Their compositions were closely similar to each 
other, and a high content of proline (about 
15 mol%) was found in both proacrosins. 
The heavy chain of human (pro)acrosin pos- 
sessed an N-terminal sequence, Ile-Val-Gly-Gly 
(residues 24-27), which was indicative of an ac- 
tivated serine protease. When the entire sequence 
of the heavy chain was compared with those of 
other human serine proteases, significant sequence 
similarities were found only between residues 24 
and 270-290 (fig.3). The percent identity of 
human (pro)acrosin with human pancreatic trypsin 
[22] was 33% in the region of residues 24-274, 
with human pancreatic kallikrein [23] 33% in the 
region of residues 24-274, with human plasmin B- 
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Fig. 1. Restriction map and sequencing strategy for the cDNA insert of human proacrosin clone H4. The restriction sites (E, EcoRI; 
B, &/II; R, RsaI: A. AM; T, TthHBfiI; St, StuI; S3, Sau3AI) were used for subcloning into M13mp18 or 19, or pUC19. Arrows 
indicate the direction and extent of each sequence determination. bp, base pair. 
Human 
Boar 
Human 
Boar 
Human 
Boar 
~~ATGGTTT#AATGcTAcu\AcTGa:ATTcIGcTGGIcm;rr;e,~Ta:Gn;GTTocT 
ht. Val Glu Met hu F'm lhr Ala Ile leu Lac Val Leu Ala Val Ser Val Val Ala 
ApA~T~~~Aa;x;TTaa:ax:TFTQ1GTTAooGTR:wGcAAAIy:ouI(ia6GGTQ[;Tm:ooCAn:m:QGcar,A#;cCrGG9 
Lys 22 g E Cys 2 G$ E Cys G$ & h-9 Phe Arg Gln Asn fku Gln Gly Gly Val kg Ile Val Gly Gly Lys Ala Ala 
: velvaIQyGly&t*Aza ____________________--_ 
~~Tm;aa:m;m:m;ATGm:wCcR:~An:TR:wGTAc-~AIy:#3ccAcTT#:(j9c#;9~QGAooCwC~cn; 
Gln His Gly Ala Trp Pru Trp Met Val Ser Leu Gln Ile Pha lhr Tyr - Asn 5er His bq Tyr His Tir Cys Gly Gly Ser ku h 
Qu~~yAL,'IZp~Rpn3tValSerLeuQnIlePIE~~~A91~Ar8~~Ifis~~Qy(;ly~LatIeu ______________________________________________________________________________________________ ______ 
AATTuI(x39m;GTGcTcAcT~GcTcpEM:~TcGn:m:AAAAATAATm;~T\Tc;ncm;#;4cn;c;rrm:~~A#;~A~ 
Asn !3er hq Trp Val Leu Tk Ala Ala His Cys Phe Val Gly Lys kn Asn Val His Asp Trp Aq Lar Val Pk Gly Ala Lp Glu Ile 
AalnHsnpvallalllrAL¶AlaHsQ6pheLJ6A¶L~ ____~~_~_~__~_______~~~~~~______~__~~~~~~~~~~~~~~~~ 
AcATATooGA#:AAT~(Tp1(;TAA#jGajccTGn;~AA(is6TAT61G6#j~An:ATcATT~T\TGpATTAcA#:TcTGaj~ 
Thr Tr Gly PM Asn Lys Pro Val Lys Ala Pm Val Gln Glu kg Tyr Val Glu Lys Ile Ile Ile His Glu Lp Tyr kn Ser Ala Tk 
~ocAAATr#:ATTGa:cn:GTGG#jATc#x:~m:ATTToGx;Tm;m:‘TTcATTou;(xx;oa:m:cTGm:w:TIGARG~ 
Glu Gly Asn Asp Ile Ala Leu Val Glu Ile Tlr Pro Pm Ile Set- Cys Gly Arg Ptw Ile Gly Pm Gly Cys Lw Pm His bu Lys Ala 
Ga:cn:ca:#;9m:nx:ur;#r:w:m;c;n;ccCm:m;~TATATA~c#jApA~m:~~TcATcTATAcR;An;c#; 
Gly ku h Arp Gly Ser Gln Ser Cys Trp Val Ala Gly Trp Gly Tyr Ile Glu Glu Lys Ala Pro Aq FYU Ser Ser Ile Leu Met Glu 
~o6TGTG69TcTcATCcAc~R;GAc~IGTGTAIy:nr,Aa:w;m;TAcAAT~oGc(iTTw;~Aa:~TTm;mCoa;TAT 
Ala h-9 Val Asp Lw Ile Asp Leu Asp Lau Cys A& Ser Thr Gln Trp Tyr kn Gly kg Val Gln Pm Tlr Asn Val Cys Ala Gly Tyr 
ccTGTAm:~An:G#:ka:mC~~acRcnCwCm:mccCrcTcAx;mClu\Ar#:wCA#;GpAwCm:TATGTGGR:GTG(jli9 
Pm Val Gly Lp Ile Asp TIP- Cys Gln Gly Asp Ser Gly Gly Pro Leu tkt Cys Lys Asp Ser Ly5 Glu 5er Ala Tyr Val Val Val Gly 
An:AEApGcm;aoCGTAm:Tc;rca:a;Tca:Aacm:m:~An:TAcwGGa:#x:m;~TATcTG'pIIy:m;An:m:Ta:~ 
Ile Thr SW Trp Gly Val Gly Cys Ala Arg Ala lys Aq h Gly Ile Tyr Thr Ala Tk Trp Pru Tyr h Asn Trp Ile Ala k b 
ATTmTcrAAC(3CTTTGaGTAn;ATTU\Anx;crr:AccccT~ax;ar:AGCACTOGI\m;m:C(I;ATT(rP1Oa:COCTR:TOCCAC 
Ile Gly Set- Asn Ala Leu kg Met Ile Gln Ser Ala Tb Pru Pro Pro Pm Thr Thr Arg Pro Ptw Ru Ile Aq h F'ru Pk SW His 
ccTAn:~ocTuy:cTTccTm;TATTTc~ca;ca:cXrra;AccSCrrocAar:a;socAar,~m:c#;ax:~~a;s~ 
Pro Ile Ser Ala His Leu h Trp Tr Fhe Gln Pro Pro h hg Pru Leu Pru F'ru Aq Pro h Ala Ala Gln Pru Arg h F'ru Pm 
TG9m:~,ax:~m:a;9clcT~m:Tu\~Am:~ax:ccAax:crp,m:a;s~ACAaX:TGPTCTACC#i9AAPI~ 
SerRo~R.oRoProPro~ProAlaSerRoLacRoProProProPro~~ProProThrProSerSerT)*~LysLeu 
(TX:~\A(FACTTTCTmoccA#;oa:A~~#;ATA6#;m:~ARGm;A#jAa:TATTCCC#:GGAA#;A#:CATTATC#: 
Pro Gln Gly Leu 5er Flw Ala Lys Aq Leu Gln Gln Leu Ile Glu Val Leu Lys Gly Lys Thr TRY Ser AW Gly Lys kn His Ty* ASP 
ATGW;Aa:fWc#;CTCoG9cAACl-GAccnr.AccKCTMTCXXClWrmc;swr,~~~ 
Met Glu Tlr lhr Glu ku Pru Glu ku Thr Set- Thr Ser 
oGAA#'ATcA MTiWTM4 TkWXTATA TATATMTA TMkWV'M /W&X4 
1: 
163 
30 
250 
59 
340 
89 
430 
119 
520 
149 
610 
179 
700 
209 
790 
239 
880 
269 
970 
299 
1060 
329 
1150 
359 
1240 
389 
1332 
402 
1388 
Fig.2. Nucleotide sequence and deduced amino acid sequence of human proacrosin. The predicted amino acid sequence is shown below 
the nucleotide sequence. The nucleotides are numbered in the 5 ’ - to 3 ’ -direction. The amino acids are numbered from the N-terminus 
of the predicted light chain sequence, and the residues from the N-terminal side of residue 1 are indicated by negative numbers. The 
N-terminal sequences of the light (wavy underline) and heavy chains (broken underline) of boar (pro)acrosin determined by the protein 
analysis [4,5,10] are also indicated. Potential N-linked glycosylation sites are marked with asterisks. A series of polyadenylation signal 
is underlined. 
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Table 1 
Amino acid composition of boar and human proacrosins 
Amino acid Residues/molecule (mol%) 
Boar proacrosin Human proacrosin 
Asx 24 (5.7) 28 (7.0) 
Thr 23 (5.5) 24 (6.0) 
Ser 24 (5.7) 28 (7.0) 
GlX 43 (10.3) 29 (7.2) 
Pro 64 (15.3) 61 (15.2) 
GlY 40 (9.6) 34 (8.5) 
Ala 28 (6.7) 27 (6.7) 
Val 26 (6.2) 20 (5.0) 
CYs 12 (2.9) 12 (3.0) 
Met 6 (1.4) 5 (1.2) 
Ile 19 (4.5) 22 (5.5) 
Leu 28 (6.7) 28 (7.0) 
Tyr 12 (2.9) 14 (3.5) 
Phe 12 (2.9) 8 (2.0) 
LYs 19 (4.5) 20 (5.0) 
His 5 (1.2) 10 (2.5) 
Arg 28 (6.7) 21 (5.2) 
Trp 5a (1.2) 11 (2.7) 
Total 418 402 
a Data from [5] 
The amino acid composition of boar proacrosin was determined 
by acid hydrolysis [lo], and the nearest integers are indicated 
chain [24] 35% in the region of residues 24-273, 
and with human factor X [25] 33% in the region of 
residues 24-292. A comparison of the amino acid 
sequence of the C-terminal portion of human pro- 
acrosin including the prohne-rich segment with the 
sequences listed in the National Biochemical 
Research Foundation protein library did not 
establish any significant sequence similarity with 
other known proteins. 
4. DISCUSSION 
Here, we have isolated a cDNA clone encoding 
a mammalian (pro)acrosin for the first time. The 
cloned human proacrosin cDNA is 1388 bp long 
(figs 1,2). Two potential ATG start codons, which 
are only 6 nucleotides apart, are found near the 
beginning of the open reading frame (fig.2). Since 
the translation of eukaryotic mRNAs is mostly in- 
itiated from the first AUG [26], we assume that the 
first ATG is the start codon of human proacrosin. 
According to Siegel et al. [18], who have recently 
purified and partially characterized human sperm 
proacrosin, the human zymogen shows an ap- 
parent molecular mass of 52-55 kDa on SDS- 
Acrosin 
g;!!!E,in 
Factor X 
Acrosin 
~#W!&in 
Factor X 
Acrosi n 
$~Wf~~ein 
Factor X 
Acrosin 
i3i#ed n 
Factor X 
100 
176 
323 
Fig.3. The deduced amino acid sequence of the human (pro)acrosin heavy chain and its sequence similarity with other human serine 
proteases. Dashes represent gaps introduced to maximize the sequence identity. The identical amino acids are indicated by black- 
background letters. The identified or predicted active site residues of serine proteases are shown by asterisks. The last amino acids 
in the human proacrosin sequence are numbered at the right. 
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polyacrylamide gel electrophoresis, and is autoac- 
tivated to a 49 kDa form followed by further con- 
version into several lower molecular mass forms. 
The activation process is very similar to that of 
boar proacrosin [6,7]. The molecular mass 
predicted for human proacrosin (43860 Da) is 
about 10 kDa lower than that determined by SDS- 
polyacrylamide gel electrophoresis [ 181. This 
discrepancy may be due to the anomalous elec- 
trophoretic behaviour of the probably glycosylated 
proacrosin. 
The deduced amino acid sequence of human 
proacrosin confirms that its mature form, acrosin, 
belongs to the serine protease family (fig.3). A se- 
quence comparison with other serine proteases in- 
dicates that His-69, Asp-123, and Ser-221, all 
located in the heavy chain, constitute the active site 
of human acrosin. Two cysteines in the light chain 
at residues 6 and 10 seem to form the interchain 
disulfide bonds with two cysteines in the heavy 
chain (probably residues 135 and 143). It is also 
likely that 4 intrachain disulfide bonds are formed 
within the heavy chain between appropriate cys- 
teine residues (probably between residues 54 and 
70, 158 and 227, 190 and 206, and 217 and 247). 
We also predict that in human acrosin the C- 
terminus of the heavy chain is either Arg-276, -289, 
-294, -314, -319, or -326. The rationale for this 
prediction is two-fold. Firstly, boar acrosin has the 
proline-rich segment as a C-terminal extension, 
which is split off during the conversion of the 
zymogen to the mature form [lo]. The proline-rich 
segment of human proacrosin is located at residues 
283-353, in particular at residues 325-353. If this 
region is cleaved off during the maturation, the 
cleavage site must be an arginine residue located at 
the N-terminal side of the proline-rich segment. 
Secondly, the stretch spanning residues 24-270 of 
the human proacrosin heavy chain exhibits signifi- 
cant sequence similarities with other serine pro- 
teases, as mentioned above, and thus eems to have 
to be retained in the active, mature enzyme. At any 
rate, it may be concluded that, like the boar en- 
zyme, human acrosin is synthesized as a single- 
chain polypeptide (proacrosin), and the zymogen is 
then converted to the mature form by the pro- 
teolytic removal of the C-terminal proline-rich seg- 
ment and by the cleavage of the peptide bond 
between the segments corresponding to the light 
and heavy chains. 
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